发现一种口服生物可用和脑透的选择性雌激素受体降解剂

Guobao Zhang1, Peter Q Huang1, Kevin D Bunker1

  • 1Zentalis Pharmaceuticals, San Diego 92121, California, United States.

概括

研究人员开发了新的口服选择性雌激素受体降解剂 (SERDs),以增强大脑透. 这些化合物在乳腺癌患者治疗大脑转移方面显著有前途.

相关概念视频

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K